Osteomepha is a drug used to treat bone weakness in postmenopausal women and prevent osteoporosis in postmenopausal women, as the risk of osteoporosis increases in them, and to enhance bone density in men.
Osteomepha treats bone weakness in men and women resulting from the use of steroids (such as cortisone) and treats Paget's disease of the bone.